Bioventus Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Bioventus Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation: Delaware
Headquarters city: Durham
Headquarters state / province: North Carolina
Headquarters country: United States
Fiscal year end: December
Ticker symbol: BVS
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001665988
EIN: 81-0980861

Board of directors

Follow this board

Ajay Dhankhar · Director
Since 2025
Anthony P. Bihl III · Director · Interim CEO
Since 2023
Guido J. Neels · Director
Since 2023
Guy P. Nohra · Director
Since 2021
John A. Bartholdson · Director
Since 2023
Kenneth Michael Reali · Director · Fmr. CEO and Director
Since 2023
Martin P. Sutter · Director
Since 2023
Mary Kay Ladone · Director
Since 2023
Michelle McMurry-Heath · Director
Since 2023
Pat Beyer · Director
Since 2023
Philip G. Cowdy · Director
Since 2025
Robert E. Claypoole · Director · President and CEO
Since 2024
Susan M. Stalnecker · Director
Since 2023
William A. Hawkins · Director
Since 2023

Chief executives

Robert E. Claypoole · President and CEO

Since January 2024

63 CEO score

Solid · grade C

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%: 63

20% of the scoring weight is on file. Figures cover December 2023 – December 2025.

Kenneth Michael Reali · Chief Executive Officer

Until April 2023 · Former

Anthony P. Bihl III · Interim CEO Interim

2023 – 2024 · Former

40 CEO score

Weak · grade F

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%: 40

20% of the scoring weight is on file. Figures cover December 2022 – December 2023.

Director election results

Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 11 other boards. 7 are in the same sector.

Shared director Other board Same sector

TELA Bio Inc. Same sector
via Guido J. Neels and Guy P. Nohra
Axogen Inc. Same sector
via Guido J. Neels
Biogen Inc. Same sector
via William A. Hawkins
Elutia Inc. Same sector
via Guido J. Neels
Inogen Inc Same sector
via Mary Kay Ladone
Kestra Medical Technologies Ltd. Same sector
via Mary Kay Ladone
Leidos Holdings Inc.
via Susan M. Stalnecker
Lincoln Educational Services Corporation
via John A. Bartholdson
MiMedx Group Inc Same sector
via William A. Hawkins
Novanta Inc.
via Mary Kay Ladone
Revvity Inc.
via Michelle McMurry-Heath

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $181,180; 2 sales by 2 insiders

Date	Insider	Transaction	Shares	Price	Value
Jun 2, 2026	John A. Bartholdson Director, 10% owner	Option exercise	+32,282	—	—
Jun 2, 2026	Martin P. Sutter Director, 10% owner	Option exercise	+32,282	—	—
Jun 2, 2026	Susan M. Stalnecker Director	Option exercise	+32,282	—	—
Jun 2, 2026	Guy P. Nohra Director	Option exercise	+32,282	—	—
Jun 2, 2026	Guido J. Neels Director	Option exercise	+32,282	—	—
Jun 2, 2026	Michelle McMurry-Heath Director	Option exercise	+32,282	—	—
Jun 2, 2026	Mary Kay Ladone Director	Option exercise	+32,282	—	—
Jun 2, 2026	William A. Hawkins Director	Option exercise	+39,789	—	—
Jun 2, 2026	Philip G. Cowdy Director	Option exercise	+32,282	—	—
Jun 2, 2026	Pat Beyer Director	Option exercise	+32,282	—	—
Apr 10, 2026	Singleton Mark Leonard Officer (SVP & CFO)	Option exercise	+13,000	—	—
Apr 10, 2026	CHURCH KATRINA J Officer (SVP & Chief Compliance Officer)	Option exercise	+4,300	—	—
Apr 10, 2026	D'Adamio Anthony Officer (SVP & General Counsel)	Option exercise	+9,925	—	—
Apr 10, 2026	Singleton Mark Leonard Officer (SVP & CFO)	Shares withheld for tax	−5,648	$9.06	$51,171
Apr 10, 2026	CHURCH KATRINA J Officer (SVP & Chief Compliance Officer)	Shares withheld for tax	−1,868	$9.06	$16,924

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Bioventus Inc.

Who is the CEO of Bioventus Inc.?

Robert E. Claypoole has been Bioventus Inc.'s President and CEO since January 2024.

How many directors are on Bioventus Inc.'s board?

Bioventus Inc.'s board has 14 directors: Ajay Dhankhar, Anthony P. Bihl III, Guido J. Neels, Guy P. Nohra, John A. Bartholdson, Kenneth Michael Reali, Martin P. Sutter, Mary Kay Ladone, Michelle McMurry-Heath, Pat Beyer and 4 others.

Are Bioventus Inc. insiders buying or selling shares?

Over the last 12 months, Bioventus Inc. insiders made no open-market purchases and sold $181,180 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Bioventus Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="bioventus-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.